 Mohammad Bilal
Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endoscopic Mucosal Resection | 12 | 2025 | 38 | 5.380 |
Why?
| | Colonoscopy | 9 | 2025 | 260 | 2.420 |
Why?
| | Colorectal Neoplasms | 7 | 2025 | 849 | 1.910 |
Why?
| | Endosonography | 4 | 2026 | 160 | 1.870 |
Why?
| | Cholecystitis, Acute | 2 | 2025 | 26 | 1.760 |
Why?
| | Adenoma | 4 | 2025 | 218 | 1.700 |
Why?
| | Drainage | 3 | 2025 | 184 | 1.700 |
Why?
| | Stents | 7 | 2026 | 557 | 1.400 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 6 | 2026 | 221 | 1.300 |
Why?
| | Percutaneous Coronary Intervention | 3 | 2021 | 547 | 1.270 |
Why?
| | Ultrasonography, Interventional | 4 | 2026 | 161 | 1.120 |
Why?
| | Myocardial Infarction | 3 | 2021 | 1209 | 1.110 |
Why?
| | Cholecystectomy | 2 | 2026 | 61 | 1.080 |
Why?
| | Adenocarcinoma | 2 | 2025 | 923 | 1.010 |
Why?
| | Duodenal Neoplasms | 2 | 2025 | 26 | 1.010 |
Why?
| | Gastrointestinal Hemorrhage | 5 | 2026 | 136 | 0.970 |
Why?
| | Gallbladder | 1 | 2025 | 15 | 0.930 |
Why?
| | Endoscopy, Gastrointestinal | 3 | 2022 | 237 | 0.910 |
Why?
| | Sphincterotomy, Endoscopic | 1 | 2025 | 29 | 0.900 |
Why?
| | Endoscopy | 3 | 2022 | 317 | 0.880 |
Why?
| | Precancerous Conditions | 1 | 2025 | 166 | 0.820 |
Why?
| | Gastroenterology | 2 | 2026 | 190 | 0.820 |
Why?
| | Stomach Neoplasms | 1 | 2025 | 130 | 0.810 |
Why?
| | Duodenal Obstruction | 1 | 2022 | 6 | 0.750 |
Why?
| | Treatment Outcome | 19 | 2026 | 11735 | 0.710 |
Why?
| | Colonic Polyps | 4 | 2025 | 85 | 0.690 |
Why?
| | Intestinal Mucosa | 2 | 2025 | 675 | 0.640 |
Why?
| | Colonic Neoplasms | 3 | 2025 | 256 | 0.510 |
Why?
| | Humans | 51 | 2026 | 144667 | 0.480 |
Why?
| | Retrospective Studies | 17 | 2026 | 17149 | 0.480 |
Why?
| | Wound Closure Techniques | 2 | 2025 | 13 | 0.460 |
Why?
| | Occult Blood | 2 | 2025 | 39 | 0.450 |
Why?
| | Postoperative Hemorrhage | 3 | 2025 | 104 | 0.440 |
Why?
| | Education, Medical, Graduate | 1 | 2020 | 562 | 0.430 |
Why?
| | Social Media | 3 | 2023 | 167 | 0.430 |
Why?
| | Product Surveillance, Postmarketing | 2 | 2025 | 73 | 0.420 |
Why?
| | Postoperative Complications | 6 | 2026 | 2950 | 0.410 |
Why?
| | Gastric Bypass | 2 | 2026 | 126 | 0.410 |
Why?
| | United States Food and Drug Administration | 2 | 2025 | 205 | 0.400 |
Why?
| | Aged, 80 and over | 5 | 2025 | 8284 | 0.390 |
Why?
| | Biomedical Research | 1 | 2020 | 712 | 0.390 |
Why?
| | Betacoronavirus | 3 | 2020 | 286 | 0.380 |
Why?
| | Curriculum | 1 | 2020 | 1063 | 0.380 |
Why?
| | Cholestasis | 2 | 2025 | 213 | 0.350 |
Why?
| | Pancreatitis | 3 | 2024 | 145 | 0.340 |
Why?
| | Middle Aged | 16 | 2026 | 35971 | 0.340 |
Why?
| | Pneumonia, Viral | 3 | 2020 | 387 | 0.330 |
Why?
| | Coronavirus Infections | 3 | 2020 | 381 | 0.330 |
Why?
| | Early Detection of Cancer | 2 | 2025 | 472 | 0.310 |
Why?
| | Aged | 10 | 2026 | 25955 | 0.300 |
Why?
| | Internship and Residency | 1 | 2020 | 1262 | 0.290 |
Why?
| | Databases, Factual | 2 | 2025 | 1494 | 0.280 |
Why?
| | Equipment Failure | 2 | 2025 | 115 | 0.270 |
Why?
| | Hemorrhage | 3 | 2023 | 813 | 0.260 |
Why?
| | United States | 6 | 2025 | 16018 | 0.240 |
Why?
| | Male | 16 | 2026 | 72431 | 0.240 |
Why?
| | Female | 18 | 2026 | 78304 | 0.240 |
Why?
| | Gastroenterostomy | 1 | 2026 | 1 | 0.240 |
Why?
| | Myotomy | 1 | 2026 | 15 | 0.240 |
Why?
| | Hemostasis, Endoscopic | 1 | 2026 | 2 | 0.240 |
Why?
| | Gastritis, Atrophic | 1 | 2025 | 5 | 0.240 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2026 | 34 | 0.230 |
Why?
| | Esophageal Motility Disorders | 1 | 2026 | 30 | 0.230 |
Why?
| | Metaplasia | 1 | 2025 | 57 | 0.230 |
Why?
| | Helicobacter Infections | 1 | 2025 | 30 | 0.230 |
Why?
| | Polyps | 1 | 2025 | 14 | 0.230 |
Why?
| | Intestinal Perforation | 3 | 2025 | 46 | 0.230 |
Why?
| | Clinical Competence | 2 | 2025 | 1237 | 0.230 |
Why?
| | Helicobacter pylori | 1 | 2025 | 45 | 0.230 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2026 | 79 | 0.230 |
Why?
| | Duodenoscopy | 1 | 2025 | 8 | 0.220 |
Why?
| | Hemostatics | 1 | 2026 | 60 | 0.220 |
Why?
| | Conversion to Open Surgery | 1 | 2025 | 22 | 0.220 |
Why?
| | Aneurysm, False | 1 | 2025 | 45 | 0.220 |
Why?
| | Antibiotic Prophylaxis | 1 | 2026 | 134 | 0.210 |
Why?
| | North America | 1 | 2025 | 312 | 0.210 |
Why?
| | Neoplasm Invasiveness | 1 | 2025 | 503 | 0.200 |
Why?
| | Rectal Neoplasms | 1 | 2025 | 158 | 0.200 |
Why?
| | Self Expandable Metallic Stents | 1 | 2023 | 17 | 0.200 |
Why?
| | Pancreatic Neoplasms | 2 | 2023 | 926 | 0.200 |
Why?
| | Pancreatic Ducts | 1 | 2024 | 81 | 0.200 |
Why?
| | Neuroendocrine Tumors | 1 | 2025 | 119 | 0.190 |
Why?
| | Prosthesis Failure | 1 | 2024 | 125 | 0.190 |
Why?
| | Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2023 | 60 | 0.190 |
Why?
| | Pancreatic Cyst | 1 | 2023 | 50 | 0.190 |
Why?
| | Esophageal Stenosis | 1 | 2023 | 60 | 0.190 |
Why?
| | Intestinal Atresia | 1 | 2022 | 17 | 0.190 |
Why?
| | Surgical Wound Infection | 1 | 2026 | 330 | 0.180 |
Why?
| | Tumor Burden | 1 | 2023 | 324 | 0.180 |
Why?
| | Dilatation | 1 | 2022 | 71 | 0.180 |
Why?
| | Feces | 1 | 2025 | 513 | 0.180 |
Why?
| | Pancreatitis, Acute Necrotizing | 1 | 2022 | 14 | 0.180 |
Why?
| | Anesthetics | 1 | 2023 | 99 | 0.180 |
Why?
| | Sutures | 1 | 2022 | 65 | 0.180 |
Why?
| | Constriction, Pathologic | 1 | 2022 | 249 | 0.170 |
Why?
| | Prevalence | 2 | 2025 | 2839 | 0.170 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2026 | 1742 | 0.170 |
Why?
| | Obesity, Morbid | 1 | 2025 | 288 | 0.170 |
Why?
| | Scholarly Communication | 1 | 2021 | 4 | 0.170 |
Why?
| | Artificial Intelligence | 1 | 2026 | 381 | 0.160 |
Why?
| | Conflict of Interest | 1 | 2021 | 54 | 0.160 |
Why?
| | Confidentiality | 1 | 2021 | 80 | 0.160 |
Why?
| | Hydrogen Peroxide | 1 | 2022 | 334 | 0.160 |
Why?
| | Endoscopy, Digestive System | 1 | 2021 | 141 | 0.150 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2023 | 1145 | 0.150 |
Why?
| | Publishing | 1 | 2021 | 115 | 0.150 |
Why?
| | Benchmarking | 1 | 2021 | 189 | 0.150 |
Why?
| | Internationality | 1 | 2020 | 154 | 0.150 |
Why?
| | Educational Measurement | 1 | 2022 | 325 | 0.150 |
Why?
| | Colon | 1 | 2022 | 307 | 0.150 |
Why?
| | Patient Discharge | 1 | 2026 | 985 | 0.150 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 2020 | 76 | 0.150 |
Why?
| | Cysts | 1 | 2020 | 112 | 0.150 |
Why?
| | Esophageal Neoplasms | 1 | 2023 | 346 | 0.150 |
Why?
| | Colon, Ascending | 1 | 2018 | 3 | 0.140 |
Why?
| | Gastrointestinal Diseases | 1 | 2020 | 217 | 0.130 |
Why?
| | Pregnancy Complications | 1 | 2023 | 586 | 0.130 |
Why?
| | Triage | 1 | 2020 | 249 | 0.130 |
Why?
| | Pandemics | 3 | 2020 | 1700 | 0.130 |
Why?
| | Duodenal Diseases | 1 | 2017 | 8 | 0.130 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2020 | 294 | 0.120 |
Why?
| | Hospital Mortality | 1 | 2020 | 1033 | 0.110 |
Why?
| | Burnout, Professional | 1 | 2020 | 483 | 0.100 |
Why?
| | Anxiety | 1 | 2020 | 1122 | 0.090 |
Why?
| | Attitude of Health Personnel | 1 | 2020 | 1180 | 0.090 |
Why?
| | Delphi Technique | 2 | 2026 | 330 | 0.090 |
Why?
| | Propensity Score | 2 | 2023 | 373 | 0.090 |
Why?
| | Prospective Studies | 4 | 2025 | 7994 | 0.080 |
Why?
| | Adult | 5 | 2025 | 40489 | 0.080 |
Why?
| | Patient Readmission | 2 | 2026 | 765 | 0.080 |
Why?
| | Risk Factors | 2 | 2023 | 10796 | 0.070 |
Why?
| | Hospitalization | 1 | 2020 | 2446 | 0.070 |
Why?
| | Cystic Duct | 1 | 2026 | 4 | 0.060 |
Why?
| | Incidence | 2 | 2023 | 2892 | 0.060 |
Why?
| | Powders | 1 | 2026 | 44 | 0.060 |
Why?
| | Minerals | 1 | 2026 | 48 | 0.060 |
Why?
| | Root Cause Analysis | 1 | 2025 | 11 | 0.060 |
Why?
| | Foreign-Body Migration | 1 | 2024 | 33 | 0.050 |
Why?
| | Surgical Instruments | 1 | 2023 | 51 | 0.050 |
Why?
| | Lasers | 1 | 2023 | 128 | 0.050 |
Why?
| | Reoperation | 1 | 2025 | 624 | 0.050 |
Why?
| | Recurrence | 1 | 2026 | 1136 | 0.050 |
Why?
| | Microscopy, Confocal | 1 | 2023 | 317 | 0.050 |
Why?
| | Anesthesia, General | 1 | 2023 | 121 | 0.040 |
Why?
| | Esophagoscopy | 1 | 2023 | 221 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2026 | 1103 | 0.040 |
Why?
| | Patients | 1 | 2023 | 182 | 0.040 |
Why?
| | Gastroenterologists | 1 | 2021 | 21 | 0.040 |
Why?
| | Necrosis | 1 | 2022 | 243 | 0.040 |
Why?
| | Computers | 1 | 2021 | 67 | 0.040 |
Why?
| | Disclosure | 1 | 2021 | 84 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2025 | 1995 | 0.040 |
Why?
| | Cecum | 1 | 2020 | 37 | 0.040 |
Why?
| | Aspirin | 1 | 2023 | 402 | 0.040 |
Why?
| | Consensus | 1 | 2022 | 475 | 0.040 |
Why?
| | Length of Stay | 1 | 2026 | 1339 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2022 | 287 | 0.040 |
Why?
| | Writing | 1 | 2021 | 102 | 0.040 |
Why?
| | Pneumoperitoneum | 1 | 2017 | 12 | 0.030 |
Why?
| | Mediastinal Emphysema | 1 | 2017 | 9 | 0.030 |
Why?
| | Body Mass Index | 1 | 2025 | 2419 | 0.030 |
Why?
| | Patient Selection | 1 | 2020 | 727 | 0.030 |
Why?
| | Odds Ratio | 1 | 2018 | 1076 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2026 | 1928 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2022 | 3414 | 0.030 |
Why?
| | Emergency Service, Hospital | 1 | 2026 | 2325 | 0.030 |
Why?
| | Mass Screening | 1 | 2021 | 1348 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 7122 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 7140 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6041 | 0.020 |
Why?
| | Young Adult | 1 | 2023 | 14122 | 0.020 |
Why?
| | Adolescent | 1 | 2023 | 22409 | 0.010 |
Why?
|
|
Bilal's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|